Home › Compare › ARUXF vs EQR

ARUXF vs EQR: Dividend Comparison 2026

ARUXF yields 44444.44% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARUXF wins by $1.4802188700273396e+23M in total portfolio value
10 years
ARUXF
ARUXF
● Live price
44444.44%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4802188700273396e+23M
Annual income
$147,369,615,738,581,320,000,000,000,000.00
Full ARUXF calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — ARUXF vs EQR

📍 ARUXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARUXFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARUXF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ARUXF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARUXF
Annual income on $10K today (after 15% tax)
$3,777,777.78/yr
After 10yr DRIP, annual income (after tax)
$125,264,173,377,794,110,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, ARUXF beats the other by $125,264,173,377,794,110,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARUXF + EQR for your $10,000?

ARUXF: 50%EQR: 50%
100% EQR50/50100% ARUXF
Portfolio after 10yr
$7.401094350136698e+22M
Annual income
$73,684,807,869,290,660,000,000,000,000.00/yr
Blended yield
99.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

ARUXF
No analyst data
Altman Z
-46.1
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARUXF buys
0
EQR buys
0
No recent congressional trades found for ARUXF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARUXFEQR
Forward yield44444.44% ✓4.73%
Annual dividend / share$2.00$2.77 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$1.4802188700273396e+23M$40.5K ✓
Annual income after 10y$147,369,615,738,581,320,000,000,000,000.00 ✓$3,819.61
Total dividends collected$1.4797905017086652e+23M$16.9K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ARUXF vs EQR ($10,000, DRIP)

YearARUXF PortfolioARUXF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$4,455,144$4,444,444.44$11,248$547.57+$4.44M → ARUXF
2$1,855,294,292$1,850,527,287.41$12,701$666.53+$1855.28M → ARUXF
3$722,201,114,647$720,215,949,754.98$14,405$814.59+$722201.10M → ARUXF
4$262,786,638,114,837$262,013,882,922,164.10$16,413$999.84+$262786638.10M → ARUXF
5$89,382,811,928,504,960$89,101,630,225,722,080.00$18,795$1,232.92+$89382811928.49M → ARUXF
6$28,419,510,536,946,614,000$28,323,870,928,183,110,000.00$21,639$1,527.95+$28419510536946.59M → ARUXF
7$8,446,906,587,814,894,000,000$8,416,497,711,540,360,000,000.00$25,057$1,903.80+$8446906587814894.00M → ARUXF
8$2,346,953,255,508,951,600,000,000$2,337,915,065,459,989,300,000,000.00$29,197$2,385.87+$2346953255508951552.00M → ARUXF
9$609,599,312,292,179,560,000,000,000$607,088,072,308,785,000,000,000,000.00$34,250$3,008.70+$609599312292179607552.00M → ARUXF
10$148,021,887,002,733,950,000,000,000,000$147,369,615,738,581,320,000,000,000,000.00$40,467$3,819.61+$1.4802188700273396e+23M → ARUXF

ARUXF vs EQR: Complete Analysis 2026

ARUXF — Stock

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.

Full ARUXF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this ARUXF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARUXF vs SCHDARUXF vs JEPIARUXF vs OARUXF vs KOARUXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.